| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 93,916 | 54,216 | 68,319 | 69,626 | | Cost of Revenue | 45,433 | 27,862 | 33,937 | 38,681 | | | Gross Profit | 48,483 | 26,354 | 34,382 | 30,945 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,826 | 25,850 | 28,034 | 26,479 | | Non Recurring |
-
|
-
|
-
| 16,230 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,657 | 504 | 6,348 | (11,764) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 350 | 719 | 151 | (1,745) | | Earnings Before Interest And Taxes | 20,007 | 1,223 | 6,499 | (13,509) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 20,007 | 1,223 | 6,499 | (13,509) | | Income Tax Expense | 6,750 | 352 | 2,279 | (4,760) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,257 | 871 | 4,220 | (8,749) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,257 | 871 | 4,220 | (8,749) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,257 | $871 | $4,220 | ($8,749) |
|
0.51% Nasdaq 
Income Statement
